Clinical Trial Update: A Natural History of Late Onset Tay-Sachs Disease

View source ↗

Summary

A completed natural history study of GM2 gangliosidosis, including late-onset Tay-Sachs disease, sponsored by Massachusetts General Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gm2 Gangliosidosis
• Late-onset Tay-sachs Disease

Snippet

Sponsor: Massachusetts General Hospital | Conditions: GM2 Gangliosidosis | Status: COMPLETED